Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10064914
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
granted patentUS 10058561
Methods and related compositions for reduction of fat and skin tightening
granted patentUS 10058572
Placenta-derived multipotent stem cells
granted patentUS 10053494
Chemically activated nanocapsid functionalized for cancer targeting
granted patentUS 10046016
Mutant adeno-associated virus virions and methods of use thereof
granted patentUS 10046057
Methods for arranging and packing nucleic acids for unusual resistance to nucleases and ta
granted patentUS 10047396
Biomarkers for diagnosis of transient ischemic attacks
granted patentUS 10041936
Neuronal cells cultured on microparticles and methods of using same
granted patentUS 10039807
bFGF-polymer conjugates, methods for making the same and applications thereof
granted patentUS 10039816
Siderophore-based immunization against gram-negative bacteria
granted patentUS 10041041
Compositions and methods for treating retinal diseases
granted patentUS 10039725
Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activ
granted patentUS 10034929
RNA interference functions as an antiviral immunity in mammals
granted patentUS 10035823
Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflamma
granted patentUS 10035981
Kidney-specific tumor vaccine directed against kidney tumor antigen G-250
granted patentUS 10029017
Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug
granted patentUS 10028936
Compositions and methods employing Wolbachia FtsZ as a target for Albendazole sulfone
granted patentUS 10028983
Compositions and methods for promoting growth of beneficial microbes to treat or prevent d
granted patentUS 10022450
Regulation of specific spinal neurons regulating pain transmission via chimeric toxins
granted patentUS 10023581
Modified cytotoxins and their therapeutic use
granted patentUS 10023588
Compositions and methods for treating cancer
granted patentUS 10016498
D-amino acid derivative-modified peptidoglycan and methods of use thereof
granted patentUS 10017551
Peptides having reduced toxicity that stimulate cholesterol efflux
granted patentUS 10016490
Multiple-enzyme nanocomplexes
granted